Form S-1/A Calidi Biotherapeutics,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20240401/A524R22CZC2R62U2222Q22Y2L7RDZZ22Q262
Filed on: April 1, 2024
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Volition's sepsis biomarker published in Critical Care Medicine
- AIAI Holdings begins acquisition talks with founder-controlled firm
- Astellas begins Phase 3 trial of ASP2138 for gastric cancer
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
